Anesthesia consideration for viteroretinal surgery 10 mark answer

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive information to write a detailed 10-mark answer. Let me compile everything.

Anesthesia Considerations for Vitreoretinal Surgery

Introduction

Vitreoretinal (VR) surgery encompasses procedures for retinal detachment repair, vitrectomy, macular surgery, proliferative vitreoretinopathy, and complex posterior segment disorders. These procedures present unique anesthetic challenges related to patient positioning, intraocular pressure (IOP) control, surgical duration, systemic comorbidities, and the use of intraocular tamponade agents. The choice of anesthesia - regional, general, or monitored anesthesia care (MAC) - must be individualized to the patient and procedure.

1. Patient Profile and Preoperative Assessment

VR surgery patients are typically elderly with significant systemic comorbidities including:

Diabetes mellitus (proliferative diabetic retinopathy being the leading indication)
Hypertension and cardiovascular disease
Autonomic dysfunction due to diabetic neuropathy, which can exaggerate hypotension under anesthesia

Preoperative assessment must include cardiac risk stratification, glycemic control, and airway evaluation. Anticoagulation management is important: VR surgery carries an intermediate hemorrhagic risk (between low-risk cataract and high-risk orbital surgery). Warfarin may be continued if INR is within therapeutic range; the risk of intraretinal, choroidal, and vitreous hemorrhage is low (<0.4%) and must be weighed against thrombotic risk on stopping anticoagulation.

Miller's Anesthesia, 10e - p. 9726

2. Choice of Anesthetic Technique

A. Regional Anesthesia (Preferred for Most Cases)

Regional anesthesia is the standard technique for vitreoretinal surgery. It provides:

Analgesia and akinesia of the globe
Lowered IOP
Good postoperative analgesia
Less postoperative nausea and vomiting (PONV) vs general anesthesia
Faster recovery and discharge

Longer-acting local anesthetics are specifically indicated for vitreoretinal surgery due to the longer operative duration. Bupivacaine (0.5%, avoiding 0.75% due to extraocular muscle toxicity risk) or ropivacaine are appropriate choices. Combining agents (e.g., lidocaine + bupivacaine) may shorten latency while maintaining duration, though dilution of each agent may reduce individual nerve penetration.

Barash Clinical Anesthesia, 9e - p. 4180

Regional options include:

Technique	Details
Retrobulbar (intraconal) block	2-5 mL injected inside the muscle cone; rapid onset, reliable akinesia; 1% risk of retrobulbar hemorrhage
Peribulbar (extraconal) block	Injected outside cone; larger volumes needed; safer profile, preferred in many US centers
Sub-Tenon block	Blunt cannula under Tenon's capsule; avoids sharp-needle risks; favored in UK/New Zealand

A facial nerve block (Van Lint or Atkinson technique) may be added to prevent lid squeeze (orbicularis oculi is outside the orbital cone).

B. General Anesthesia - Specific Indications

General anesthesia is required for:

Pediatric patients
Cognitively impaired or uncooperative adults
Complex vitreoretinal procedures requiring profound muscle relaxation (where any patient movement could result in instrument injury to intraocular structures)
Penetrating keratoplasty combined with vitrectomy
Open-sky procedures

Endotracheal intubation (not LMA) is required for vitreoretinal procedures demanding muscle relaxation. Neuromuscular blockade must be profound (0/4 twitches on nerve stimulator; monitored by nerve stimulator throughout). Rocuronium or vecuronium can be reversed with sugammadex.

Miller's Anesthesia, 10e - p. 9745

TIVA with propofol is preferred over volatile agents to minimize PONV, which is particularly detrimental as vomiting/straining raises IOP dramatically.

C. MAC (Monitored Anesthesia Care) with Sedation

Most adult VR surgery under regional block is supplemented with MAC sedation (midazolam, propofol infusion, or dexmedetomidine). The anesthesiologist must:

Monitor vital signs continuously
Be vigilant for oculocardiac reflex
Watch for signs of brainstem anesthesia or intravascular local anesthetic injection

3. Intraocular Pressure (IOP) Control

Controlling IOP is a central concern in VR surgery. Acutely elevated IOP before scleral incision can result in:

Iris or lens prolapse
Vitreous loss
Expulsive suprachoroidal hemorrhage - the most feared complication

Maneuvers to lower IOP preoperatively/intraoperatively:

IV acetazolamide (carbonic anhydrase inhibitor)
IV mannitol (osmotic agent - to "soften" the globe)
Adequate akinesia via regional block (extraocular muscle relaxation lowers IOP)
Avoid: succinylcholine (raises IOP by 6-8 mmHg for 5-10 min due to EOM fasciculation - avoid in open-globe cases; use rocuronium instead)
Avoid: coughing, bucking, straining, Valsalva (dramatically elevate IOP)
Prevent hypercapnia (CO2 raises IOP by vasodilation)
Barash Clinical Anesthesia, 9e - p. 4188

4. The Oculocardiac Reflex (OCR)

VR surgery - particularly scleral buckling procedures with globe manipulation and traction on extraocular muscles - can elicit the OCR:

Arc: Afferent via trigeminal (V1, short ciliary nerves) → brainstem → vagus efferent
Manifestation: Bradycardia, junctional rhythm, ventricular ectopy, asystole
Management:
- Stop surgical stimulus immediately
- Atropine IV (10-20 mcg/kg; adult 0.4-0.6 mg) or glycopyrrolate
- Deepening anesthesia may help obtund the reflex
- Retrobulbar block reduces OCR incidence
- Hypercarbia augments the reflex and should be avoided

The OCR is self-limiting if stimulus is removed but must be anticipated throughout scleral buckle and vitrectomy procedures.

5. Nitrous Oxide (N₂O) and Intraocular Gas Tamponade - Critical Interaction

This is one of the most important and unique considerations in VR anesthesia.

Intraocular gas tamponades used in VR surgery include:

Air
Sulfur hexafluoride (SF6) - absorbed over ~10 days
Perfluoropropane (C3F8) - persists up to 28-70 days

N₂O is absolutely contraindicated when intraocular gas is present because:

N₂O (blood:gas coefficient 0.47) rapidly diffuses into any gas-filled cavity far faster than nitrogen diffuses out
This causes dramatic expansion of the gas bubble: SF6 bubble volume increases >3-fold with N₂O/O2 vs. only ~50% increase with air
Acute bubble expansion raises IOP dangerously, causing retinal vascular occlusion and blindness
Visual loss has been reported with N₂O use as long as 41 days after vitrectomy with C3F8 tamponade

Practical implications:

N₂O must be discontinued 15-20 minutes before intraocular gas injection during the same case
Patients who have received intraocular gas must wear a medical alert bracelet/wristband to warn any future anesthesiologist
If the patient presents for surgery within the gas-absorption window (up to 8+ weeks for C3F8), anesthesia must be maintained with air/oxygen or air/oxygen/volatile agent - NO N₂O
Miller's Anesthesia, 10e - p. 4491; Kanski's Clinical Ophthalmology, 10e

6. Positioning Considerations

Patients are typically supine, often with head turned 90 degrees away from the anesthesiologist
This means the airway is remote from the anesthesia provider - a critical concern if airway problems arise
After silicone oil or gas tamponade injection, patients may require prolonged face-down (prone) positioning postoperatively to keep the tamponade in contact with the retina - this should be discussed in the anesthetic plan
Prolonged prone positioning itself carries risks: pressure injuries, venous congestion, and rarely ischemic optic neuropathy

7. PONV Prevention

PONV is particularly harmful in VR surgery because:

Retching and vomiting sharply elevate IOP
May disrupt a fresh vitreoretinal repair
Increases PACU stay and risk of unplanned admission

Multimodal prophylaxis is recommended:

TIVA with propofol (intrinsically antiemetic)
Ondansetron (5-HT₃ antagonist) + dexamethasone
Avoid opioids where possible (use regional/sub-Tenon block for postoperative analgesia)
Regional anesthesia itself reduces PONV compared to GA

8. Airway Management - Smooth Emergence

Coughing, straining, or bucking on the endotracheal tube at extubation can spike IOP and risk vitreoretinal repair disruption. Key strategies:

Deep extubation (where appropriate) or LMA removal when patient is still well anesthetized
IV lidocaine 1-1.5 mg/kg before suctioning/extubation to blunt cough reflex
Adequate reversal confirmed to prevent residual paralysis and re-narcotization (use sugammadex for full reversal of rocuronium)
Consider remifentanil infusion continued to extubation to suppress cough

9. Drug Interactions Relevant to VR Surgery

Drug	Consideration
Succinylcholine	Raises IOP 6-8 mmHg; avoid in open globe; use rocuronium 1.2 mg/kg for RSI if needed
Ketamine	Raises IOP; generally avoided (though studies are conflicting at sub-dissociative doses)
Volatile agents	Lower IOP; acceptable but TIVA preferred to reduce PONV
Mannitol	Can cause diuresis; monitor fluid status, electrolytes
Acetazolamide	Metabolic acidosis with prolonged use; hypokalemia
Epinephrine (intracameral)	Potential systemic absorption causing hypertension/tachycardia

10. Diabetic Patient Considerations

Many VR surgery patients have proliferative diabetic retinopathy. Additional concerns:

Gastroparesis - increased aspiration risk; consider RSI if symptomatic
Autonomic neuropathy - exaggerated hypotension under anesthesia; treat with phenylephrine infusion, not repeated boluses
Glycemic control - target glucose 140-180 mg/dL intraoperatively
Renal impairment - adjust drug dosing; caution with mannitol and NSAIDs

Summary Table

Domain	Key Consideration
Technique	Regional (retrobulbar/peribulbar/sub-Tenon) for most; GA for complex/pediatric cases
Local anesthetic	Longer-acting (bupivacaine 0.5%, ropivacaine) for vitreoretinal duration
IOP	Avoid succinylcholine, coughing, N₂O; use mannitol/acetazolamide if needed
Nitrous oxide	Absolutely contraindicated with intraocular gas (SF6, C3F8, air) - risk of blindness
OCR	Anticipate during globe manipulation; treat with atropine, cessation of stimulus
PONV	Multimodal prophylaxis; TIVA preferred; regional block for postoperative analgesia
Airway	Smooth extubation; deep extubation or IV lidocaine to prevent cough/IOP spike
Comorbidities	Diabetes (gastroparesis, autonomic neuropathy), hypertension, anticoagulation management

Sources:

Miller's Anesthesia, 2-Volume Set, 10e (Chapters 65 and Chapter on Positioning/Visual Loss) - Miller's Anesthesia, 10e, p. 9724-9746, p. 4491
Barash, Cullen & Stoelting's Clinical Anesthesia, 9e (Chapter 49: Ophthalmic Anesthesia) - Barash, 9e, p. 4163-4190
Kanski's Clinical Ophthalmology, 10e (Tamponading agents section)

This is a shared conversation. Sign in to Orris to start your own chat.